LNP Encapsuled by Microfluid Mixing

• 

  Enhanced drug delivery with LNP encapsulation

  An interesting feature of microfluidic mixing is the ability to tailor saRNA-LNP Encapsulation Protocol  formulations specifically for different types of medicines. The way a chef would alter a recipe to make something taste better, scientists can change the chemical composition of the lipid nanoparticle to generate capsules that could serve distinct functionalities depending on the type of medicine.

• 

  Tailored LNP formulations using microfluidic mixing

  Advances in the stabilization of Tissue-targeting RNA-LNP Development constitute an additional key consideration. The process is less efficient than with native molecules because it requires a greater amount of protein and cost to make the capsules more stable (beyond our control) because if they are kept at room temperature they would lose their effect after two days. That means drugs can be stored under less ideal conditions and still have a longer shelf-life before pharmaceuticals are distributed and used.

• 

  Advancements in LNP encapsulation technology through microfluidic mixing.

  One area of research is also operating on enhancing the targeting of LNP capsules toward certain cell types. By developing LNP capsules that can do a better job of locating and entering the correct cells, scientists can promote greater medicine efficacy while reducing potential side effects. So these LNP capsules work like targeted delivery service that know where to go, and can deliver the medicine to the correct spot of the body.

Why choose Yaohai LNP Encapsuled by Microfluid Mixing?

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and LNP Encapsuled by Microfluid Mixing. We have developed a solid quality system that adheres to current GMP standards and regulatory requirements worldwide. Our regulatory team is knowledgeable on global regulatory frameworks to expedite biological launches. We make sure that production processes are traceable with high-quality products as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also in compliance. Yaohai BioPharma successfully passed an on-site audit conducted by a Qualified Person from the European Union (QP) to examine our GMP process and manufacturing facility. We also successfully been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Customization, Efficiency & Cost-Effectiveness

  LNP Encapsuled by Microfluid Mixing has experience in manufacturing biologics that are that are derived from microorganisms. We provide tailored RD as well as manufacturing solutions, while minimising the risk. We have experimented with a variety of techniques, such as recombinant cellular subunits of vaccines (including peptides), growth factors, hormones and the cytokines. We have specialized in multiple microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion bodies (yields up to 10g/L). We also have the BSL-2 fermentation platform to develop bacterial vaccines. We are experts in improving processes, increasing product yields, and decreasing production costs. With an effective technology team, we ensure timely and quality project delivery and bring your products to market faster.

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 LNP Encapsuled by Microfluid Mixing of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading microbial biologics CDMO. Our main focus has been the production of LNP Encapsuled by Microfluid Mixing and therapeutics to treat pets, human and veterinary health. We have state-of-the-art RD platforms and manufacturing technology that cover the entire manufacturing process beginning with the development of microbial strains Cell banking, process and method development, through commercial and clinical manufacture that ensures the successful delivery of innovative solutions. Over time we've gained a vast knowledge of microbial-based bio processing. We have successfully completed more than 200 global projects, and help our clients with navigating the rules and regulations of the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react promptly to market demands and provide tailored CDMO services due to our experience and expertise.

Related product categories

• Analytical Methods for Plasmid DNA
• Bacteriophage AP205 VLP Manufacturing
• Bacteriophage Q VLP Manufacturing
• Chimeric VLP Vaccine Manufacturing
• Conjugate VLP Vaccines Manufacturing
• DNA Vaccine Manufacturing
• E. coli Fermentation for VLP Production
• GLP-1 Agonist Manufacturing
• GLP-1 Analog Manufacturing

Not finding what you're looking for?
Contact our consultants for more available products.